Recent advances in antibiotics.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D002509:Cephaloridine / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005672:Fusidic Acid / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008034:Lincomycin / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D009675:Novobiocin / Q000627:therapeutic use; D010303:Paromomycin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013752:Tetracycline / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D005839:Gentamicins; D010406:Penicillins; D011113:Polymyxins; D009675:Novobiocin; D007612:Kanamycin; D005672:Fusidic Acid; D010303:Paromomycin; D004917:Erythromycin; D002701:Chloramphenicol; D008034:Lincomycin; D013752:Tetracycline; D009355:Neomycin; D002509:Cephaloridine; D013307:Streptomycin; D003091:Colistin